<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03172715</url>
  </required_header>
  <id_info>
    <org_study_id>Dnro 6U/2017</org_study_id>
    <nct_id>NCT03172715</nct_id>
  </id_info>
  <brief_title>Prosthesis Versus Osteosynthesis in Proximal Tibia Fractures</brief_title>
  <acronym>POSITIF</acronym>
  <official_title>Prosthesis Versus Osteosynthesis in Treatment of Intra-articular Fractures of Proximal Tibia: A Randomized, Controlled, Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Finland Hospital District</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Coxa, Hospital for Joint Replacement</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seinajoki Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Paijat-Hame Hospital District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Finland Hospital District</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare knee function and pain one year after treatment of
      intra-articular proximal tibia fracture using either osteosynthesis with a locking plate
      (ORIF) or primary total knee replacement (TKR) in patients over 65 years of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intra-articular proximal tibial fractures are relatively common in the elderly. They
      constitute 8% of all fractures in patients over 65 years. Open reduction and internal
      fixation (ORIF) is the golden standard treatment for these fractures.

      The treatment with ORIF is associated with significant co-morbidity due to complicating
      concomitant factors, such as osteoporosis, poor co-operation, infection and inadequate
      stability of osteosynthesis. A high failure rate (30-79 %) of fixation of tibia plateau
      fractures in elderly people has been reported. Most of these fractures occur in elderly
      persons who are at risk to lose their ability to walk independently, because of partial
      immobilization is required initially and full weight bearing is not allowed during 6 to 8
      weeks after the operation. The risk of post-traumatic osteoarthritis has been reported to be
      5.3-times higher than in the normal population even if adequate stability is achieved and
      other conditions normalized for fracture healing. It has also been reported that total knee
      replacement (TKR) performed for post-traumatic arthritis after tibial plateau fracture lead
      to worse outcome compared with TKR due to primary osteoarthritis. In addition, previous
      operations increase the risk of complications after TKR. The complication rate in secondary
      TKR has been reported to be over 18 %.

      The available data regarding TKR as a primary treatment option for proximal tibial plateau
      fracture suggest that fast mobilization and return to normal daily activities may be
      achieved. These data also suggest a low rate of complications. There are no randomized
      controlled trials comparing the outcomes of the traditional treatment option (open reduction-
      internal fixation, ORIF) and TKR as primary treatment of these fractures. In this study
      investigators compare the outcomes of locking plate osteosynthesis and total knee
      arthroplasty according to Oxford knee score, pain, ability to walk, or quality of life one
      year after randomization in 98 patients aged over 65 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Anticipated">June 2029</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee function</measure>
    <time_frame>12 months</time_frame>
    <description>Oxford knee score 12 months after randomisation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in knee function</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Change in Oxford knee score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pain</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Numeric rating scale (rest, night, exercise)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physical performance</measure>
    <time_frame>6 weeks (TKR only), 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Short Physical Performance Battery (SPPB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Short form-36 (SF-36)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperations</measure>
    <time_frame>Up to 10 years following randomisation</time_frame>
    <description>Need for revision surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Satisfaction with knee (Numeric rating scale)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain medication</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Pain medication used (pills per day)</description>
  </other_outcome>
  <other_outcome>
    <measure>Complications</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Any complication following injury or treatment</description>
  </other_outcome>
  <other_outcome>
    <measure>Medical and social services (quantity)</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Use of medical and social services (quantity)</description>
  </other_outcome>
  <other_outcome>
    <measure>Medical and social services (costs)</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years</time_frame>
    <description>Costs of medical and social services used</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">98</enrollment>
  <condition>Tibial Fractures</condition>
  <arm_group>
    <arm_group_label>ORIF (open reduction-internal fixation)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Osteosynthesis with locking plate(s) will be performed using medial and/or lateral incision, according to morphology of the fracture. Additional osteosynthesis material will be used when necessary. The articular surface will be reduced and bone transplantation or bone substitute used if required.
Postoperatively, touch-down weight bearing will be allowed for 6 weeks, followed by 2 weeks of half-weight-bearing period. A walker or wheelchair will be used when necessary.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TKR (total knee replacement)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arthroplasty of the knee will be performed within two weeks after the fracture. Medial parapatellar approach will be used. The minimal possible constraint of the prosthesis (cruciate retaining, posterior cruciate sacrificing or semi-constrained) will be used. A possible insufficient bone stock may be rebuilt with augments. Hinged prosthesis will be used only if stability of the medial collateral ligament is insufficient. A cemented or uncemented tibial stem extender (minimum length 50mm) will be used in all cases. Additional osteosynthesis will be used when necessary. Postoperatively, the patients will be allowed full weight bearing as tolerated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Locking plate</intervention_name>
    <description>Osteosynthesis</description>
    <arm_group_label>ORIF (open reduction-internal fixation)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TKR</intervention_name>
    <description>Total knee arthroplasty</description>
    <arm_group_label>TKR (total knee replacement)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute intra-articular proximal tibia fracture with impression of the joint cartilage
             (Schatzker grades II to VI)

          -  Impression of tibial plateau min 2 mm

          -  Intact patellar tendon

          -  The patient accepts both treatment options (osteosynthesis and arthroplasty)

        Exclusion Criteria:

          -  Not voluntary

          -  Previous arthroplasty of the knee

          -  Previous fracture affecting the knee joint

          -  Inability to co-operate

          -  Not independent (institutionalized living before fracture)

          -  Severe osteoarthritis (Kellgren-Lawrence grade 4)

          -  Open fracture (Gustilo grade 2 or over)

          -  Progressive metastatic malign disease

          -  Multiple fractures requiring operative treatment

          -  Severe soft tissue injury around the knee (Tscherne classification grade 3)

          -  Avulsion fracture of the patellar tendon or concomitant patellar tendon tear

          -  Inability to walk before fracture

          -  Severe medical comorbidities

          -  Body Mass Index over 40

          -  Unacceptably high risk of surgery due to severe medical comorbidities

          -  Significant arterial or nerve trauma

          -  Severe substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juha Paloneva, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Finland Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juha Paloneva, MD, PhD</last_name>
    <phone>+358 14 2693119</phone>
    <email>juha.paloneva@ksshp.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Central Finland Hospital</name>
      <address>
        <city>Jyväskylä</city>
        <zip>40620</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juha Paloneva, MD, PhD</last_name>
      <phone>+358 14 2693119</phone>
    </contact>
    <contact_backup>
      <last_name>Valtteri Tapper, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Alar Toom, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valtteri Tapper, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juha Paloneva, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heikki Nurmi, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maija Pesola, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Konsta Pamilo, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jussi Jalkanen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jussi Jalkanen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tommi Kääriäinen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Päijät-Häme Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jussi Haapala, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jussi Haapala, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sami Nurmi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tuukka Niinimäki, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Tuukka Niinimäki, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tero Kortekangas, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seinäjoki Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Janne Jousmäki, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Janne Jousmäki, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ville Sumuvuori, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coxa Joint Replacement Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jyrki Nieminen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jyrki Nieminen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Minna Laitinen, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ilari Pajamäki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Niko Strandberg, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Niko Strandberg, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mika Junnila, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Houdek MT, Watts CD, Shannon SF, Wagner ER, Sems SA, Sierra RJ. Posttraumatic Total Knee Arthroplasty Continues to Have Worse Outcome Than Total Knee Arthroplasty for Osteoarthritis. J Arthroplasty. 2016 Jan;31(1):118-23. doi: 10.1016/j.arth.2015.07.022. Epub 2015 Jul 17.</citation>
    <PMID>26264176</PMID>
  </reference>
  <reference>
    <citation>Wasserstein D, Henry P, Paterson JM, Kreder HJ, Jenkinson R. Risk of total knee arthroplasty after operatively treated tibial plateau fracture: a matched-population-based cohort study. J Bone Joint Surg Am. 2014 Jan 15;96(2):144-50. doi: 10.2106/JBJS.L.01691.</citation>
    <PMID>24430414</PMID>
  </reference>
  <reference>
    <citation>Somersalo A, Paloneva J, Kautiainen H, Lönnroos E, Heinänen M, Kiviranta I. Incidence of fractures requiring inpatient care. Acta Orthop. 2014 Sep;85(5):525-30. doi: 10.3109/17453674.2014.908340. Epub 2014 Apr 3.</citation>
    <PMID>24694275</PMID>
  </reference>
  <reference>
    <citation>Malviya A, Reed MR, Partington PF. Acute primary total knee arthroplasty for peri-articular knee fractures in patients over 65 years of age. Injury. 2011 Nov;42(11):1368-71. doi: 10.1016/j.injury.2011.06.198. Epub 2011 Jul 18.</citation>
    <PMID>21763651</PMID>
  </reference>
  <reference>
    <citation>Kini SG, Sathappan SS. Role of navigated total knee arthroplasty for acute tibial fractures in the elderly. Arch Orthop Trauma Surg. 2013 Aug;133(8):1149-54. doi: 10.1007/s00402-013-1792-8. Epub 2013 Jun 16.</citation>
    <PMID>23771128</PMID>
  </reference>
  <reference>
    <citation>Shimizu T, Sawaguchi T, Sakagoshi D, Goshima K, Shigemoto K, Hatsuchi Y. Geriatric tibial plateau fractures: Clinical features and surgical outcomes. J Orthop Sci. 2016 Jan;21(1):68-73. doi: 10.1016/j.jos.2015.09.008. Epub 2015 Dec 6.</citation>
    <PMID>26671570</PMID>
  </reference>
  <reference>
    <citation>Haufe T, Förch S, Müller P, Plath J, Mayr E. The Role of a Primary Arthroplasty in the Treatment of Proximal Tibia Fractures in Orthogeriatric Patients. Biomed Res Int. 2016;2016:6047876. doi: 10.1155/2016/6047876. Epub 2016 Jan 18.</citation>
    <PMID>26885510</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Finland Hospital District</investigator_affiliation>
    <investigator_full_name>Juha Paloneva</investigator_full_name>
    <investigator_title>Department head, adjunct professor</investigator_title>
  </responsible_party>
  <keyword>Open reduction internal fixation</keyword>
  <keyword>Arthroplasty</keyword>
  <keyword>Surgery</keyword>
  <keyword>Randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

